Evidence map›Paper›PMID 15378088›Full record

ReviewOncogene2004

Does the reservoir for self-renewal stem from the ends?

Lea Harrington

Abstract readReview
PubMed Publisher
In one paragraph

Review in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Are hematopoietic stem cells involved in hepatocarcinogenesis?Hepatobiliary surgery and nutrition · 2014
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Cancer stem cells-clinical relevance.Journal of molecular medicine (Berlin, Germany) · 2009
    Review
  15. Article
  16. Article
  17. Small intestinal stem cell markers.Journal of anatomy · 2008
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lea HarringtonDepartment of Medical Biophysics, Ontario Cancer Institute, University of Toronto, 620 University Avenue, Canada M5G 2C1. leah@uhnres.utoronto.ca

Funding

GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1R01AG016629 · NIA · ONTARIO CANCER INSTITUTE · PI HARRINGTON, LEA A. · 1999 to 2003
$646k
NIA NIH HHS AG16629-04
6 · The paper itself

Abstract

Stem cell research is a burgeoning field with an alluring potential for therapeutic intervention, and thus begs a critical understanding of the long-term consequences of stem cell replacement. Operationally, a stem cell may be defined as a rarely dividing cell with the capacity for self-renewal throughout the lifetime of the organism, and an ability to reconstitute its appropriate lineages via proliferation and differentiation. In many differentiated normal and cancer cell types, the maintenance of telomeres plays a pivotal role in their continued division potential. Taken together with the presence of the enzymatic activity responsible for telomere addition, telomerase, in several progenitor cell lineages, it is presumed that telomere maintenance will be critical for the replenishment of stem cells or their successors. The purpose of this review is to discuss the role of telomere length maintenance in self-renewal, and the consequent challenges and potential pitfalls to the manipulation of normal and cancer-derived stem cells.

Indexed as

AnimalsArabidopsisArabidopsis ProteinsCell DivisionDNA ReplicationEukaryotaHomeostasisHumansMiceModels, BiologicalNeoplasm ProteinsNeoplastic Stem CellsProtozoan ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsStem CellsArabidopsis ProteinsNeoplasm ProteinsProtozoan ProteinsSaccharomyces cerevisiae ProteinsTelomerase

Identifiers

PMID15378088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.